Jonathan is the Senior Vice President of Finance at Myeloid Therapeutics where he leads all aspects of the Company’s finance, accounting and treasury functions. Prior to Myeloid, Jonathan was a Vice President of Finance at Alexion Pharmaceuticals where he led the finance and accounting for Alexion’s genomic medicines division. Prior to Alexion, Jonathan was the Vice President of Finance at LogicBio Therapeutics, where he was responsible for all aspects of the financial operations including overseeing the controllership function, public company reporting and financial planning and analysis. Earlier in his career, Jonathan held roles of increasing responsibility at Karyopharm Therapeutics and Celldex Therapeutics. Jonathan began his career at PricewaterhouseCoopers LLP within the firm’s Transaction Advisory Group. Jonathan is a Certified Public Accountant in the State of Massachusetts and graduated summa cum laude from Providence College with a B.S. in Accountancy.